Rinsho Shinkeigaku (Clinical Neurology)


The second paradigm shift occurred on acute stroke therapy

Teruyuki Hirano, M.D., Ph.D.1)

1)Departement of Stroke and Cerebrovascular Medicine, Kyorin University

Outcome of acute stroke patients with embolic large vessel occlusion can be improved dramatically, if the effective and rapid reperfusion of the occluded vessel achieved. Since 2015, when the evidence of acute endovascular therapy established its efficacy, such scenario became no longer uncommon. Along with introduction of direct oral anticoagulant (DOAC), many options of antithrombotic therapy for acute ischemic stroke also became available. This review summarize the recent advances on acute ischemic stroke therapy.
Full Text of this Article in Japanese PDF (553K)

(CLINICA NEUROL, 57: 203|207, 2017)
key words: acute ischemic stroke, acute therapy, thrombectomy, direct oral anticoagulant (DOAC), dual antiplatelet therapy (DAPT)

(Received: 6-Feb-17)